US Patent Litigations are now available. Check here

Explore Medivation Prostate Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jun 12, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3725778Aug 18, 2021Formulations Of Enzalutamide11
EP2739153Aug 22, 2018Treatment Of Breast Cancer2